SCHEMBL25972070

SCHEMBL25972070

C[C@@H]1CCN(C(=O)c2ccc(C(C)(C)C)cn2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.49
▸ PLA2G1B P04054 1/20 0.47
▸ ATG4B Q9Y4P1 1/20 0.47
▸ LMNA P02545 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ RECQL P46063 1/20 0.43
▸ L3MBTL3 Q96JM7 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ LIPE Q05469 2/20 0.40
▸ GRM5 P41594 1/20 0.40
▸ SCN9A Q15858 6/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25972082 0.92 HPGD (0.50) ALDH1A1PLA2G1BATG4BLMNAGAA
SCHEMBL25972074 0.89 ALDH1A1 (0.45) ALDH1A1PLA2G1BATG4BLMNAGAA
SCHEMBL23880061 0.87 SCN9A (0.49) ALDH1A1PLA2G1BATG4BL3MBTL3L3MBTL1
SCHEMBL23880057 0.84 SCN9A (0.47) ALDH1A1PLA2G1BATG4BHPGDL3MBTL3
SCHEMBL23880060 0.81 SCN9A (0.46) ALDH1A1PLA2G1BATG4BHPGDL3MBTL3
SCHEMBL2733495 0.80 SMN1; SMN2 (0.65) ALDH1A1GAAHPGDMEN1KMT2A
SCHEMBL15470654 0.79 MEN1 (0.60) ALDH1A1LMNAGAAHPGDRECQL
SCHEMBL10203177 0.79 L3MBTL3 (0.67) ALDH1A1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL23880056 0.78 ALDH1A1 (0.48) ALDH1A1PLA2G1BATG4BL3MBTL3L3MBTL1
SCHEMBL25972071 0.76 ALDH1A1 (0.47) ALDH1A1PLA2G1BATG4BL3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725012-B2 Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitors BEIGENE, LTD. (KY) 2023-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725012-B2 Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitors PIK3CD, PIK3R5, PIK3CA ALDH1A1 1955/4885PLA2G1B 1312/4885ATG4B 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback